cisplatin,erdafitinib,gemcitabine,mitomycin
janssen
['uste ', 'mibc', 'erdafitinib', ' cis ', 'nmibc', 'erda', 'thor-2', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', ' gem ', 'gemcitabine', 'mitomycin', 'marker ']
phase 2 study of the efficacy and safety of erdafitinib in pts with bcg-unresponsive, hr-#nmibc with fgfr3/2 alterations in thor-2: cohort 2 interim analysis. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology